Marc Wolfgang is Vice President of Technical Operations at BioNTech US, overseeing manufacture and supply chain of T-cell therapies. Marc has over 30 years’ experience in the biotech/pharma industry, holding various positions in manufacturing, CMC, quality and regulatory affairs at Neon Therapeutics, Cerulean Pharma, Momenta Pharmaceuticals, Millennium Pharmaceuticals, Biogen and Boehringer Ingelheim Pharmaceuticals. Marc has a B.S. degree in Biology and M.S. degree in chemistry. He is former Chairman of the Nanomedicines Alliance and a former steering committee member for AAPS’s Nanotechnology Focus Group.